Article info

Download PDFPDF
Letter
Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment

Authors

  1. Correspondence to Dr Ho Jin Kim, Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang 410-769, South Korea; hojinkim{at}ncc.re.kr
View Full Text

Citation

Kim S, Kim Y, Kim G, et al
Less frequent rituximab retreatment maintains remission of neuromyelitis optica spectrum disorder, following long-term rituximab treatment

Publication history

  • Received March 20, 2018
  • Revised May 23, 2018
  • Accepted May 26, 2018
  • First published June 21, 2018.
Online issue publication 
April 09, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.